FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure FDA takes first step in possible reversal of ban on some peptides The Washington Post In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law